慢性阻塞性肺疾病药物市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00016845
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Chronic Obstructive Pulmonary Disease Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

市场介绍 慢性阻塞性肺疾病是一种以长期呼吸困难和低气流为特征的阻塞性肺疾病。主要症状包括呼吸急促和咳嗽咳痰。慢性阻塞性肺病是一种进行性疾病,这意味着它通常会随着时间的推移而恶化。两种不同类型的慢性阻塞性肺病是肺气肿和慢性支气管炎。慢性支气管炎是两年内每年至少出现三个月的咳嗽症状。患有这种咳嗽的人患慢性阻塞性肺病的风险更大。肺气肿也用于组织内异常的空气或其他气体。最常见的原因是吸烟,少数病例是由于空气污染和遗传所致。在发展中国家,常见的空气污染源是木材燃烧和烹饪用火。此外,长期暴露于这些危险因素会导致肺部炎症反应,导致小气道变窄和肺组织破裂。慢性阻塞性肺病是根据肺功能测试测量的低气流来诊断的。 市场动态 慢性阻塞性肺疾病药物市场在预测期内呈现出显着的演变。关键驱动因素包括慢性阻塞性肺病发病率和患病率增加、技术进步以及人口老龄化。据美国人口普查局统计,截至2021年,65岁及以上的人口总数超过5000万。据联合国称,2015年至2030年期间,全球60岁老年人数量预计将从9.01亿增加到14亿以上。导致慢性阻塞性肺病的重要因素包括接触空气污染、香烟烟雾、罕见遗传病、化学烟雾或灰尘等。 《柳叶刀呼吸医学》在 2021 年发表了一篇文章,指出慢性阻塞性肺病 (COPD) 造成的永久性肺组织损伤甚至在患者出现任何症状之前就开始了。此外,技术进步预计将提供利润丰厚的市场机会。然而,传统治疗的局限性,例如起效晚和疗效低,以及严格的政府法规可能会限制市场的增长。 市场范围 《至2031年慢性阻塞性肺疾病药物市场分析》是对医疗保健行业药品的专业深入研究,重点关注全球市场趋势分析。本报告概述了慢性阻塞性肺疾病药物市场,并按疾病类型、治疗方法和最终用户进行了详细的市场细分。预计慢性阻塞性肺疾病药物市场在预测期内将出现高速增长。该报告重点关注慢性阻塞性肺疾病药物市场主要参与者的市场状况的重要统计数据,并提供主要趋势和机会。 市场细分 市场根据疾病类型、治疗方法和最终用户进行细分。根据疾病类型,市场分为肺气肿和慢性支气管炎。根据治疗方法,市场分为支气管扩张剂、类固醇、抗炎药等。根据最终用户,市场分为医院、诊所和其他。

Chronic Obstructive Pulmonary Disease Drugs Market: Strategic Insights

Chronic Obstructive Pulmonary Disease Drugs Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Mylan N V
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Abbott
  • Astellas Pharma
  • Circassia Pharmaceuticals plc
  • Pfizer Inc

Regional Overview

Regional And Country Scope
  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

Segment 1疾病类型
  • 肺气肿
  • 慢性支气管炎
Segment2治疗
  • 支气管扩张剂
  • 类固醇
  • 消炎药等
Segment3最终用户
  • 医院
  • 诊所
  • 其他
Segment4地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
该报告列出了该行业的详细轮廓,包括定性和定量信息。该报告根据各个细分市场对慢性阻塞性肺疾病药物市场进行了概述和预测。它还包括 2021 年至 2031 年五个主要地区的市场规模和预测估计:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美洲和中美洲。然后将每个地区的市场细分为各自的国家和细分市场。该报告对全球十八个国家以及该地区的近期趋势和机遇进行了分析和预测。报告从需求和供给两个方面分析了影响慢性阻塞性肺疾病药物市场的因素。此外,它还评估预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还包括对所有五个地区的精确 PEST 分析,即:北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲,在评估了影响这些地区慢性阻塞性肺疾病药物市场的政治、经济、社会和技术因素后。 市场参与者 该报告包含了慢性阻塞性肺疾病药物市场作为有机和无机增长策略的关键发展。许多企业都专注于有机增长战略,例如产品发布、产品批准以及其他(例如专利和活动)。市场上观察到的无机增长策略是收购、伙伴关系和合作。这些活动为市场参与者扩大业务和客户群铺平了道路。随着全球慢性阻塞性肺疾病药物市场需求的不断增长,预计慢性阻塞性肺疾病药物市场的市场参与者将在未来几年获得盈利增长机会。以下是几家从事慢性阻塞性肺疾病药物市场的公司名单。该报告还包括慢性阻塞性肺疾病药物市场主要参与者的概况,以及他们的 SWOT 分析和市场策略。此外,该报告还详细介绍了领先的行业参与者,包括公司概况、所提供的组件和服务、过去三年的财务信息、过去五年的关键发展信息。
    • 阿斯利康 • 勃林格殷格翰国际有限公司 • Mylan NV • 梯瓦制药工业有限公司 • 葛兰素史克公司 • 雅培 • 安斯泰来制药 • Circassia 制药公司 • 辉瑞公司。 • F。 Hoffmann-La Roche Ltd
Insight Partner 的专业研究和分析团队由经验丰富的专业人士组成,具有先进的统计专业知识,并在当前研究中提供各种定制选项。

Chronic Obstructive Pulmonary Disease Drugs Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 疾病类型
  • 肺气肿
  • 慢性支气管炎
By 治疗
  • 支气管扩张剂
  • 类固醇
  • 消炎药等
By 最终用户
  • 医院
  • 诊所
  • 其他
By 地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太地区其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Mylan N V
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Abbott
  • Astellas Pharma
  • Circassia Pharmaceuticals plc
  • Pfizer Inc
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. AstraZeneca
    2. Boehringer Ingelheim International GmbH
    3. Mylan N.V.
    4. Teva Pharmaceutical Industries Ltd
    5. GlaxoSmithKline plc
    6. Abbott
    7. Astellas Pharma
    8. Circassia Pharmaceuticals plc
    9. Pfizer Inc.
    10. F. Hoffmann-La Roche Ltd

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..